Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by elviradyer208on Feb 03, 2022 12:59pm
246 Views
Post# 34393761

Exxon Makes Biggest Profit in 7 Years as Oil Prices Rise

Exxon Makes Biggest Profit in 7 Years as Oil Prices Rise
User image
 
Exxon Mobil Corp, the oil and gas giant from the United States, reported a profit of US$ 8.87 billion or around Rp. 126.8 trillion in the fourth quarter of 2021. This achievement was the largest in the last seven years due to soaring world energy prices.
 
The company cut spending after demand for fuel declined two years ago. But since then, earnings have topped pre-pandemic levels, helped by rising oil prices, with global oil benchmark Brent also at its highest level in seven years.
 
Exxon also revealed a business overhaul to accelerate a $6 billion cut in operating costs that began last year.
 
The revamp will "position us to lead cash flow and revenue growth, operating performance, and the energy transition," Exxon Chief Executive Darren Woods said in a statement.
 
The continuation of high oil prices will "cause us to increase the pace of our share buyback program," said Chief Financial Officer Kathryn Mikells.
 
Exxon began share buybacks last month after a lengthy holdout, with a pledge to buy $10 billion by the end of 2023.
 
"ExxonMobil closed a turbulent year with results that can be described as solid," Peter McNally, global sector leader at research firm Third Bridge.
 
Exxon reported adjusted earnings of $2.05 per share, 11 cents above analyst estimates as earnings benefited from soaring oil and gas prices, higher volume and asset sales. In the same quarter of 2020, Exxon posted adjusted earnings of 3 cents per share.
 
Oil and gas production, Exxon's largest business, posted an operating profit of $6.1 billion, its highest in two years. This achievement was benefited by an 80% increase in oil prices and a doubling of natural gas prices compared to 2020.
 
Now the company plans to increase production in the US shale oil basin by 25% this year, in addition to a similar increase last year in the Permian, where output stood at 460,000 barrels per day (bpd).
 
Meanwhile, Exxon's oil refinery business posted a fourth-quarter net operating profit of $1.4 billion, up consecutively and a big swing from 2020 when results were hurt by a pandemic-related decline in demand.
 
Chemicals operating revenues more than doubled profits in the same period last year when businesses were hurt by the pandemic. Exxon said Monday that it will combine its refinery and chemicals businesses

https://wadeszig.vip/exxon-makes-biggest-profit-in-7-years-as-oil-prices-rise/
https://www.cakeresume.com/me/shelib
https://muckrack.com/pergio-longali/bio
https://vocus.cc/article/61fc0eeafd897800014713af
https://issuu.com/risnakamira10
https://www.gdpr.associates/community/profile/r2852312/
https://www.xp-pen.com/forum-5872.html
https://chopatti.com/forum/topic/beautiful-athletes-who-stole-attention-in-the-world-of-athletics
https://fstu.org/forum/open-forum/265515
https://myclc.clcillinois.edu/web/jeff_test/tutoring/-/message_boards/message/32603662
https://www.mydigoo.com/forums-topicdetail-406990.html
https://www.mychemicalromance.com/news/beautiful-athletes-who-stole-attention-world-athletics-number-1-won-status-sexiest-athlete
https://www.shadowville.com/board/general-discussions/ahead-of-the-sea-games-vietnam-2021#p512792
https://healthymboa.org/forum-healthymboa/topic/nft-digital-asset-fraud-is-increasing-and-disturbing/#postid-41374
 
<< Previous
Bullboard Posts
Next >>